[1]
“DEMERGER, A PANACEA FOR CORPORATE PROBLEMS - A CASE STUDY ON CROMPTON GREAVES LIMITED”, Journal of Pharmaceutical Negative Results, pp. 1507–1511, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.200.